Biotricity, Inc. to Present at Maxim Group's 2021 Inaugural Emerging Growth Virtual Conference
03/15/2021 - 08:00 AM
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that CEO Waqaas Al-Siddiq will present at Maxim Group's Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021.
Dr. Al-Siddiq will participate in a Healthcare IT panel on Thursday March 18th from 3:30-4:30 PM Eastern Time (12:30-1:30 PM Pacific) and a fireside chat with Maxim analyst Allen Klee on Friday March 19th, from 11:30-12:00 AM Eastern Time (8:30-9:00 AM Pacific). To access these sessions, investors should register for the conference here . Following the conclusion of the conference, investors can also request a one-on-one meeting with Biotricity management by contacting investor relations.
About Biotricity Inc.
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic products for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com .
Contacts:
Investor Relations:investors@biotricity.com
Todd Kehrli or Mark Forneybtcy@mkr-group.com
SOURCE: Biotricity, Inc.
View source version on accesswire.com:
https://www.accesswire.com/635360/Biotricity-Inc-to-Present-at-Maxim-Groups-2021-Inaugural-Emerging-Growth-Virtual-Conference
BTCY Rankings
N/A Ranked by Stock Gains
BTCY Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Packaged Software, Technology Services, Manufacturing, Surgical and Medical Instrument Manufacturing
About BTCY
biotricity is a medical technology company committed to improving healthcare by developing solutions that aid chronic disease prevention and management. biotricity’s premier product is bioflux, an ecg monitoring system that will be prescribed by physicians to diagnose and remotely monitor cardiac patients. biotricity is expanding medical-grade monitoring into the consumer market via its biolife solution, which empowers users to self-manage chronic conditions. biolife helps users make lifestyle changes by combining medically relevant ecg data with social media interactivity and a lifestyle log. biotricity’s r&d continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. the company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system.
